We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $34.9B
1-Year Est. Return 18.88%
This Fund
S&P 500
This Quarter Est. Return
+5.64%
1 Year Est. Return
+18.88%
3 Year Est. Return
+73.84%
5 Year Est. Return
+90.13%
10 Year Est. Return
+512.03%
AUM
$11.3B
AUM Growth
+$589M
Cap. Flow
+$20.5M
Cap. Flow %
0.18%
Top 10 Hldgs %
17.02%
Holding
1,387
New
148
Increased
486
Reduced
533
Closed
92

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$47.4M
2
AGN
Allergan plc
AGN
+$38.9M
3
NVRO
NEVRO CORP.
NVRO
+$24.1M
4
NFLX icon
Netflix
NFLX
+$21.5M
5
WM icon
Waste Management
WM
+$21.3M

Sector Composition

Rank Sector Weight
1 Healthcare 19.99%
2 Technology 15.43%
3 Financials 11.87%
4 Industrials 11.27%
5 Consumer Discretionary 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACN icon
51
Accenture
ACN
$102B
$60.7M 0.54%
496,832
+12,251
+3% +$1.4M
TSCO icon
52
Tractor Supply
TSCO
$16.1B
$60.1M 0.53%
4,458,550
+255,485
+6% +$4.25M
VUG icon
53
Vanguard Morningstar Growth ETF
VUG
$220B
$59.2M 0.52%
3,161,562
-346,680
-10% -$6.45M
UPS icon
54
United Parcel Service
UPS
$88.6B
$59M 0.52%
539,430
+3,252
+0.6% +$355K
JPM icon
55
JPMorgan Chase
JPM
$935B
$58M 0.51%
871,341
+13,475
+2% +$879K
PG icon
56
Procter & Gamble
PG
$336B
$58M 0.51%
645,834
-3,055
-0.5% -$265K
PYPL icon
57
PayPal
PYPL
$48.9B
$57.7M 0.51%
1,407,765
+32,611
+2% +$1.25M
LOW icon
58
Lowe's Companies
LOW
$117B
$55.4M 0.49%
767,776
+5,458
+0.7% +$424K
BKNG icon
59
Booking.com
BKNG
$149B
$55M 0.49%
934,125
-18,200
-2% -$1.01M
INGN icon
60
Inogen
INGN
$175M
$54.7M 0.48%
912,789
-82
-0% -$4.57K
NTRS icon
61
Northern Trust
NTRS
$33.3B
$53.2M 0.47%
782,020
-10,469
-1% -$711K
XRAY icon
62
Dentsply Sirona
XRAY
$2.68B
$52.6M 0.46%
884,741
+1,064
+0.1% +$65.4K
CHKP icon
63
Check Point Software Technologies
CHKP
$13B
$52.5M 0.46%
676,352
-126
-0% -$9.77K
SRCL
64
DELISTED
Stericycle Inc
SRCL
$52.4M 0.46%
653,245
-128,314
-16% -$11.6M
AGN
65
DELISTED
Allergan plc
AGN
$51.7M 0.46%
224,422
+159,152
+244% +$38.9M
PRAA icon
66
PRA Group
PRAA
$663M
$51.5M 0.46%
1,491,744
+683
+0% +$20.1K
XOM icon
67
ExxonMobil
XOM
$644B
$50.5M 0.45%
578,209
+4,237
+0.7% +$376K
VEEV icon
68
Veeva Systems
VEEV
$33.1B
$50M 0.44%
1,212,123
+108,680
+10% +$4.21M
ABMD
69
DELISTED
Abiomed Inc
ABMD
$49.7M 0.44%
386,609
+2,614
+0.7% +$313K
ABBV icon
70
AbbVie
ABBV
$443B
$47.5M 0.42%
752,836
-51,603
-6% -$3.34M
FTV icon
71
Fortive
FTV
$17.9B
$47.4M 0.42%
+1,476,720
New +$47.4M
AMT icon
72
American Tower
AMT
$80.8B
$46.6M 0.41%
411,559
+24,235
+6% +$2.77M
BRK.B icon
73
Berkshire Hathaway Class B
BRK.B
$1.1T
$45.8M 0.4%
316,813
-48,547
-13% -$7.1M
FISV
74
Fiserv Inc
FISV
$28.8B
$44.2M 0.39%
888,162
-1,736
-0.2% -$91K
BFAM icon
75
Bright Horizons
BFAM
$3.92B
$43.9M 0.39%
655,751
+6,218
+1% +$419K

Similar funds

William Blair & Company's Q3 2016 Portfolio in Review

As of Q3 2016, William Blair & Company held 1,387 positions worth $11.3B, up 5.5% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

William Blair & Company's Q3 2016 filing shows 148 new, 486 increased, 533 reduced and 92 closed positions. Its largest new stake was Fortive: 1,476,720 shares worth $47.4M. The largest sale was Gilead Sciences, an estimated $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.

  • William Blair & Company's largest Q3 2016 buy was Fortive: 1,476,720 shares worth $47.4M.
  • William Blair & Company added most to Allergan plc in Q3 2016, an estimated $38.9M increase.
  • William Blair & Company's biggest Q3 2016 reduction was Gilead Sciences, cutting an estimated $45.3M.
  • William Blair & Company fully exited IHS INC CL-A COM STK in Q3 2016, selling an estimated $6.24M.
  • William Blair & Company's ten largest holdings make up 17% of its $11.3B portfolio in Q3 2016.
  • William Blair & Company opened 148 new positions and closed 92 in Q3 2016.
  • William Blair & Company's portfolio value rose 5.5% quarter-over-quarter to $11.3B.

Based on William Blair & Company's 13F filing for Q3 2016, filed 14 Nov 2016.